Dr. Slagle is a scientific and regulatory expert, providing advice on patient centered drug development to drug product developers. Formerly with the US FDA Clinical Outcome Assessment (COA) Staff, her experience includes over 15 years of policy analysis and outcomes research, including COA development, implementation, and analysis to evaluate treatment benefit for regulatory purposes. She received her PhD in Pharmaceutical Health Services Research from the University of MD, Baltimore.